Pricing Drugs

Health Affairs - United States
doi 10.1377/hlthaff.22.6.284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Health Affairs (Project Hope)

Related search

Pricing in the Market for Anticancer Drugs

2015English

The Pricing of Breakthrough Drugs: Theory and Policy Implications

PLoS ONE
Multidisciplinary
2014English

Higher Prices From Entry: Pricing of Brand-Name Drugs

SSRN Electronic Journal
1995English

Pcp37 - The Confidentiality Regarding Drugs Pricing and Reimbursement in Romania

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Regulation, Pricing of Drugs and Parallel Trade in Czech Republic

2016English

Substantiation of the National Policy of Pricing and Availability of Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Reference Pricing on Biotherapeutic Drugs: Monitoring of the Insulin Wholesale Prices in Ukraine

Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï
2016English

Pricing of Innovative Drugs: Correlation Between Incremental Cost and Survival Gain in Four Countries

Therapeutic Advances in Medical Oncology
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy